Ascensia Diabetes Care And Senseonics Announced That Medicare Has Expanded Access To Eversense E3 CGM System, With Implementation Of Local Coverage Determinations To Access Implantable CGM For Basal-Only Patients, By First Three Medicare Contractors
Ascensia Diabetes Care And Senseonics Announced That Medicare Has Expanded Access To Eversense E3 CGM System, With Implementation Of Local Coverage Determinations To Access Implantable CGM For Basal-Only Patients, By First Three Medicare Contractors
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.